《2016年 NCCN 宫颈癌临床实践指南》解读

摘要

National Comprehensive Cancer Network( NCCN) is an academic institution that composed of 21 authoritative cancer research centers in United States. Every year NCCN regularly publishes a variety of clinical practice guidelines of malignant tumor. NCCN Clinical Practice Guidelines in Oncology:Cervical Cancer developed by NCCN is the using standard of clinical decision of gynecological tumor in America,and also recognized by gynecologic oncologists worldwide and becomes the most widely used guideline around the world. In our country,because of the differences in health care system, medical level and patient factors,it has certain degree of difficulty in directly applying this guideline,but it can also be used as an important reference of clinical diagnosis and treatment of cervical cancer patients. The paper makes a brief interpretation and explanation of NCCN Clinical Practice Guidelines in Oncology:Cervical Cancer(Version 1. 2016),and mainly combines it with medical practice and clinical practice in our country. The purpose is to help clinicians better understand,inquire and apply of the content of NCCN Clinical Practice Guidelines in Oncology:Cervical Cancer(Version 1. 2016).%美国国立综合癌症网络（NCCN）是美国地区21家权威肿瘤研究中心组成的学术机构，每年定期公布多种恶性肿瘤临床实践指南。其制定的《NCCN 宫颈癌临床实践指南》是美国妇科肿瘤临床决策的使用标准，也被全球妇科肿瘤专家认同并成为世界范围内应用最广泛的指南。在我国，由于医疗体制、医疗水平和患者因素等情况的差异，直接应用该指南存在一定程度的困难，但仍可作为宫颈癌患者临床诊治实践的重要参考。本文对《2016年 NCCN宫颈癌临床实践指南》进行简要解读和阐释，重点与我国医疗和临床工作实际相结合，目的是帮助临床更好地了解、查询和应用《2016年 NCCN 宫颈癌临床实践指南》中的内容。